Nerve growth factor and mast cell distribution in the skin of patients with systemic sclerosis.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 8353988)

Published in Clin Exp Rheumatol on September 23, 1993

Authors

M A Tuveri1, G Passiu, A Mathieu, L Aloe

Author Affiliations

1: II Chair of Rheumatology, University of Cagliari, Italy.

Articles by these authors

Effects of computer-based clinical decision support systems on clinician performance and patient outcome. A critical appraisal of research. Ann Intern Med (1994) 17.27

Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus (2000) 2.40

Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med (1998) 2.23

Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A (1994) 1.97

Metabolic syndrome--neurotrophic hypothesis. Med Hypotheses (2005) 1.78

A double-blinded evaluation of propacetamol versus ketorolac in combination with patient-controlled analgesia morphine: analgesic efficacy and tolerability after gynecologic surgery. Anesth Analg (1999) 1.67

Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) (1999) 1.66

Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci U S A (1996) 1.58

Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell (1996) 1.57

Inadvertent intracranial introduction of a nasogastric tube, a complication of severe maxillofacial trauma. Anesthesiology (1975) 1.55

Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors. Proc Natl Acad Sci U S A (2001) 1.53

Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci U S A (2001) 1.47

Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res (1977) 1.43

Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology (2000) 1.35

Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology (2008) 1.35

PREOP: development of an evidence-based expert system to assist with preoperative assessments. Proc Annu Symp Comput Appl Med Care (1991) 1.30

Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas. Invest Ophthalmol Vis Sci (2000) 1.27

Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol (1995) 1.26

Effects of electro-acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries. Biol Reprod (2000) 1.23

Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Proc Natl Acad Sci U S A (1986) 1.22

Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases. Invest Ophthalmol Vis Sci (1998) 1.21

The alpha1 subunit of the sodium pump could represent a novel target to combat non-small cell lung cancers. J Pathol (2007) 1.21

Nerve growth factor-induced transformation of immature chromaffin cells in vivo into sympathetic neurons: effect of antiserum to nerve growth factor. Proc Natl Acad Sci U S A (1979) 1.20

Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid. Neurosci Lett (1992) 1.19

Chloroquine-treatment failure in northern Ghana: roles of pfcrt T76 and pfmdr1 Y86. Ann Trop Med Parasitol (2005) 1.18

Nerve growth factor induces volume increase and enhances tyrosine hydroxylase synthesis in chemically axotomized sympathetic ganglia of newborn rats. Proc Natl Acad Sci U S A (1975) 1.17

A critical appraisal of the literature on the effects of computer-based clinical decision support systems on clinician performance and patient outcomes. Proc Annu Symp Comput Appl Med Care (1992) 1.14

Nerve growth factor release by human synovial fibroblasts prior to and following exposure to tumor necrosis factor-alpha, interleukin-1 beta and cholecystokinin-8: the possible role of NGF in the inflammatory response. Clin Exp Rheumatol (2003) 1.14

The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. Rheumatology (Oxford) (2008) 1.12

Management of neurotrophic keratopathy. Curr Opin Ophthalmol (1999) 1.09

Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allergy Clin Immunol (1997) 1.09

Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc Natl Acad Sci U S A (1999) 1.08

Effect of rituximab on clinical and laboratory features of antiphospholipid syndrome: a case report and a review of literature. Lupus (2008) 1.07

Experimental immunity to a metabolite of halothane and fluroxene: cutaneous delayed-type hypersensitivity. Anesthesiology (1974) 1.07

What are subcutaneous adipocytes really good for? Exp Dermatol (2007) 1.06

Proliferation and phenotype regulation in the subventricular zone during experimental allergic encephalomyelitis: in vivo evidence of a role for nerve growth factor. Proc Natl Acad Sci U S A (1998) 1.06

Increased levels of NGF in sera of systemic lupus erythematosus patients. Neuroreport (1993) 1.03

Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE. Clin Exp Rheumatol (1998) 1.03

NGF, BDNF, leptin, and mast cells in human coronary atherosclerosis and metabolic syndrome. Arch Physiol Biochem (2001) 1.01

The Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis. Clin Exp Rheumatol (1993) 1.00

Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch Clin Exp Ophthalmol (1997) 1.00

Sacral insufficiency fractures: an easily overlooked cause of back pain in elderly women. Arch Intern Med (1996) 1.00

Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol (1998) 1.00

Mechanism of action of nerve growth factor and cyclic AMP on neurite outgrowth in embryonic chick sensory ganglia: demonstration of independent pathways of stimulation. Proc Natl Acad Sci U S A (1973) 1.00

Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer. Br J Cancer (2011) 0.98

NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet (2000) 0.98

Increased number of mast cells in the central nervous system of adult male mice following chronic subordination stress. Brain Behav Immun (1998) 0.98

Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project". Autoimmun Rev (2005) 0.97

Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration. J Neurosci Res (2000) 0.97

Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. J Invest Dermatol (1994) 0.97

Nerve growth factor: neurotrophin or cytokine? Int Arch Allergy Immunol (2003) 0.96

Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96

Effect of topical application of nerve-growth factor on pressure ulcers. Lancet (1999) 0.96

Nerve growth factor: an important molecule in allergic inflammation and tissue remodelling. Int Arch Allergy Immunol (1999) 0.95

Remitting asymmetrical pitting oedema in systemic lupus erythematosus: two cases studied with magnetic resonance imaging. Joint Bone Spine (2000) 0.95

Light and electron microscopic studies on the excessive growth of sympathetic ganglia in rats injected daily from birth with 6-OHDA and NGF. Arch Ital Biol (1975) 0.95

Predictive factors of hand radiographic lesions in systemic sclerosis: a prospective study. Ann Rheum Dis (2010) 0.95

Differentiating effects of murine nerve growth factor in the peripheral and central nervous systems of Xenopus laevis tadpoles. Proc Natl Acad Sci U S A (1985) 0.94

Detection of early impairment of coronary flow reserve in patients with systemic sclerosis. Ann Rheum Dis (2003) 0.94

A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia. Genes Immun (2008) 0.93

Central nervous system lupus: a clinical approach to therapy. Lupus (2003) 0.93

Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis. Clin Exp Rheumatol (2010) 0.92

Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology (Oxford) (2002) 0.92

Cyclocytidine-induced release of nerve growth factor from mouse submandibular glands enhances regeneration of sympathetic fibers in adult mice. Brain Res (1985) 0.92

Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis and relationship to conjunctival mast cells. Invest Ophthalmol Vis Sci (1995) 0.91

The galectin family and digestive disease. J Pathol (2008) 0.91

Reaction to ketamine: anaphylactoid or anaphylactic? Br J Anaesth (1975) 0.90

NGF expression in the developing rat brain: effects of maternal separation. Brain Res Dev Brain Res (2000) 0.90

Human monocyte/macrophages activate by exposure to LPS overexpress NGF and NGF receptors. J Neuroimmunol (2001) 0.90

Electroacupuncture counteracts the development of thermal hyperalgesia and the alteration of nerve growth factor and sensory neuromodulators induced by streptozotocin in adult rats. Diabetologia (2011) 0.90

Absence of epicardial coronary stenosis in patients with systemic sclerosis with severe impairment of coronary flow reserve. Ann Rheum Dis (2006) 0.90

[Arterial manifestations of Behçet's disease. 12 cases]. Rev Med Interne (1989) 0.90

RT-PCR ELISA method for the analysis of neurotrophin mRNA expression in brain and peripheral tissues. J Biotechnol (2000) 0.89

Nerve growth factor delays retinal degeneration in C3H mice. Graefes Arch Clin Exp Ophthalmol (1996) 0.89

Isotonic saline loading and intrarenal distribution of glomerular filtration in dogs. Kidney Int (1972) 0.89

Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study. Lupus (2013) 0.88

Somatic and behavioral postnatal effects of fetal injections of nerve growth factor antibodies in the rat. Nature (1981) 0.88

Time-course changes of nerve growth factor, corticotropin-releasing hormone, and nitric oxide synthase isoforms and their possible role in the development of inflammatory response in experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A (1997) 0.88

Role of IL-1 beta and TNF-alpha in the regulation of NGF in experimentally induced arthritis in mice. Rheumatol Int (1998) 0.88

Involvement of interleukin-1beta in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat. Neuroscience (1999) 0.87

Efficacy of chloroquine in the treatment of uncomplicated, Plasmodium falciparum malaria in northern Ghana. Ann Trop Med Parasitol (2002) 0.87

Nerve growth factor and brain-derived neurotrophic factor in human paediatric hemimegalencephaly. Neuropediatrics (2004) 0.87

Learning performances, brain NGF distribution and NPY levels in transgenic mice expressing TNF-alpha. Behav Brain Res (2000) 0.87

Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European Concerted Action on the Immunogenetics of SLE. J Rheumatol (2000) 0.86

Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission. Clin Rheumatol (2008) 0.86

HLA-DP genotyping in patients with systemic lupus erythematosus: correlations with autoantibody subsets. J Rheumatol (1992) 0.86

Mycobacterium tuberculosis lipoarabinomannan antibodies are associated to rheumatoid arthritis in Sardinian patients. Clin Rheumatol (2014) 0.86

HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus (2000) 0.86

Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression. Neuroreport (2000) 0.86

High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its low affinity receptor (p75-NGFr) in male rat brain. J Neurosci Res (1997) 0.86

Social withdrawal, neophobia, and stereotyped behavior in developing rats exposed to neonatal asphyxia. Psychopharmacology (Berl) (2004) 0.86

Maturation of the hypothalamic control of pulsatile gonadotropin-releasing hormone secretion at onset of puberty. I. Increased activation of N-methyl-D-aspartate receptors. Endocrinology (1990) 0.86

Subepicardial adipose tissue in human coronary atherosclerosis: another neglected phenomenon. Atherosclerosis (2001) 0.86